Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

Details for Australian Patent Application No. 2002356962 (hide)

International Classifications

Event Publications

27 March 2003 Complete Application Filed

Priority application(s): 60/342,585 19.12.01 US; 60/340,772 12.12.01 US

28 August 2003 Application Open to Public Inspection

Published as AU-B-2002356962

9 February 2006 Amendment Made

The nature of the amendment is: Amend the name of the applicant from The Government of the United States of America as represented by The Secretary, Department of Healthand Human Services to The Government of the United States of America as represented by The Secretary, Department of Health and Human Services

19 April 2007 Application Accepted

Published as AU-B-2002356962

4 October 2007 Standard Patent Sealed

6 December 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 24 Oct 2007. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004 2003

1 May 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 24 Oct 2007 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.